Interruption of tumor dormancy by a transient angiogenic burst within the tumor microenvironment

Stefano Indraccolo, Laura Stievano, Sonia Minuzzo, Valeria Tosello, Giovanni Esposito, Erich Piovan, Rita Zamarchi, Luigi Chieco-Bianchi, Alberto Amadori

Research output: Contribution to journalArticle

Abstract

Tumor growth is currently viewed as a phenomenon associated with neovascularization and sustained production of angiogenic factors, but whether a transient angiogenic switch may trigger tumor growth remains unclear. Here, we report that leukemia cells (MOLT-3) were poorly angiogenic and remained dormant when injected s.c. into immunodeficient mice. However, progressive growth of lymphoid tumors was invariably recorded when irradiated angiogenic cells from Kaposi's sarcoma (KS-IMM) were locally coinjected with MOLT-3 cells or administered later. The persistence of KS-IMM cells in vivo was tracked by flow cytometry and real-time PCR analysis, and it was limited to a few days, during which angiogenesis was induced and preceded tumor growth. The engraftment of other types of poorly tumorigenic cancer cells was also greatly improved by irradiated KS-IMM cells. Moreover, short-term treatment with angiogenic factors, including basic FGF or VEGF, either given as recombinant factors or delivered by retroviral vectors, also accelerated tumor growth. These findings may emphasize that tumor angiogenesis is a process requiring a higher amount of angiogenic factors for its induction than maintenance.

Original languageEnglish
Pages (from-to)4216-4221
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume103
Issue number11
DOIs
Publication statusPublished - Mar 14 2006

Fingerprint

Tumor Microenvironment
Angiogenesis Inducing Agents
Neoplasms
Growth
Kaposi's Sarcoma
Vascular Endothelial Growth Factor A
Real-Time Polymerase Chain Reaction
Flow Cytometry
Leukemia
Maintenance

Keywords

  • Angiogenesis
  • Basic FGF
  • Leukemia
  • VEGF

ASJC Scopus subject areas

  • General
  • Genetics

Cite this

Interruption of tumor dormancy by a transient angiogenic burst within the tumor microenvironment. / Indraccolo, Stefano; Stievano, Laura; Minuzzo, Sonia; Tosello, Valeria; Esposito, Giovanni; Piovan, Erich; Zamarchi, Rita; Chieco-Bianchi, Luigi; Amadori, Alberto.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 103, No. 11, 14.03.2006, p. 4216-4221.

Research output: Contribution to journalArticle

@article{0950b4b3807c456881aeb18e7d3f394a,
title = "Interruption of tumor dormancy by a transient angiogenic burst within the tumor microenvironment",
abstract = "Tumor growth is currently viewed as a phenomenon associated with neovascularization and sustained production of angiogenic factors, but whether a transient angiogenic switch may trigger tumor growth remains unclear. Here, we report that leukemia cells (MOLT-3) were poorly angiogenic and remained dormant when injected s.c. into immunodeficient mice. However, progressive growth of lymphoid tumors was invariably recorded when irradiated angiogenic cells from Kaposi's sarcoma (KS-IMM) were locally coinjected with MOLT-3 cells or administered later. The persistence of KS-IMM cells in vivo was tracked by flow cytometry and real-time PCR analysis, and it was limited to a few days, during which angiogenesis was induced and preceded tumor growth. The engraftment of other types of poorly tumorigenic cancer cells was also greatly improved by irradiated KS-IMM cells. Moreover, short-term treatment with angiogenic factors, including basic FGF or VEGF, either given as recombinant factors or delivered by retroviral vectors, also accelerated tumor growth. These findings may emphasize that tumor angiogenesis is a process requiring a higher amount of angiogenic factors for its induction than maintenance.",
keywords = "Angiogenesis, Basic FGF, Leukemia, VEGF",
author = "Stefano Indraccolo and Laura Stievano and Sonia Minuzzo and Valeria Tosello and Giovanni Esposito and Erich Piovan and Rita Zamarchi and Luigi Chieco-Bianchi and Alberto Amadori",
year = "2006",
month = "3",
day = "14",
doi = "10.1073/pnas.0506200103",
language = "English",
volume = "103",
pages = "4216--4221",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "11",

}

TY - JOUR

T1 - Interruption of tumor dormancy by a transient angiogenic burst within the tumor microenvironment

AU - Indraccolo, Stefano

AU - Stievano, Laura

AU - Minuzzo, Sonia

AU - Tosello, Valeria

AU - Esposito, Giovanni

AU - Piovan, Erich

AU - Zamarchi, Rita

AU - Chieco-Bianchi, Luigi

AU - Amadori, Alberto

PY - 2006/3/14

Y1 - 2006/3/14

N2 - Tumor growth is currently viewed as a phenomenon associated with neovascularization and sustained production of angiogenic factors, but whether a transient angiogenic switch may trigger tumor growth remains unclear. Here, we report that leukemia cells (MOLT-3) were poorly angiogenic and remained dormant when injected s.c. into immunodeficient mice. However, progressive growth of lymphoid tumors was invariably recorded when irradiated angiogenic cells from Kaposi's sarcoma (KS-IMM) were locally coinjected with MOLT-3 cells or administered later. The persistence of KS-IMM cells in vivo was tracked by flow cytometry and real-time PCR analysis, and it was limited to a few days, during which angiogenesis was induced and preceded tumor growth. The engraftment of other types of poorly tumorigenic cancer cells was also greatly improved by irradiated KS-IMM cells. Moreover, short-term treatment with angiogenic factors, including basic FGF or VEGF, either given as recombinant factors or delivered by retroviral vectors, also accelerated tumor growth. These findings may emphasize that tumor angiogenesis is a process requiring a higher amount of angiogenic factors for its induction than maintenance.

AB - Tumor growth is currently viewed as a phenomenon associated with neovascularization and sustained production of angiogenic factors, but whether a transient angiogenic switch may trigger tumor growth remains unclear. Here, we report that leukemia cells (MOLT-3) were poorly angiogenic and remained dormant when injected s.c. into immunodeficient mice. However, progressive growth of lymphoid tumors was invariably recorded when irradiated angiogenic cells from Kaposi's sarcoma (KS-IMM) were locally coinjected with MOLT-3 cells or administered later. The persistence of KS-IMM cells in vivo was tracked by flow cytometry and real-time PCR analysis, and it was limited to a few days, during which angiogenesis was induced and preceded tumor growth. The engraftment of other types of poorly tumorigenic cancer cells was also greatly improved by irradiated KS-IMM cells. Moreover, short-term treatment with angiogenic factors, including basic FGF or VEGF, either given as recombinant factors or delivered by retroviral vectors, also accelerated tumor growth. These findings may emphasize that tumor angiogenesis is a process requiring a higher amount of angiogenic factors for its induction than maintenance.

KW - Angiogenesis

KW - Basic FGF

KW - Leukemia

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=33645226260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645226260&partnerID=8YFLogxK

U2 - 10.1073/pnas.0506200103

DO - 10.1073/pnas.0506200103

M3 - Article

C2 - 16537511

AN - SCOPUS:33645226260

VL - 103

SP - 4216

EP - 4221

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 11

ER -